Insulet
PODD
#1051
Rank
A$28.18 B
Marketcap
$401.86
Share price
-0.40%
Change (1 day)
48.80%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.46 Billion

According to Insulet's latest financial reports the company's current earnings are A$1.87 Billion. In 2023 the company made an earning of A$0.38 Billion, an increase over its 2022 earnings that were of A$66.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.46 B19.04%
2023 A$0.38 B481.9%
2022 A$66.58 M-45.24%
2021 A$0.12 B43.35%
2020 A$84.81 M18.51%
2019 A$71.57 M41.16%
2018 A$50.7 M-711.95%
2017 -A$8.29 Million-56.85%
2016 -A$19.21 Million-79.31%
2015 -A$92.83 Million63.85%
2014 -A$56.66 Million31.04%
2013 -A$43.24 Million-21.96%
2012 -A$55.41 Million
2010 -A$52.84 Million-42.38%
2009 -A$91.71 Million-33.56%
2008 -A$0.14 Billion65.93%
2007 -A$83.19 Million209.75%
2006 -A$26.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.34 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.22 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.17 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.41 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.47 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.72 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$15.68 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA